SHOP
Whole Body O2 Brain O2 Immune O2 Fatigue O2 Glossary Intended Use
New User Onboarding Whole Body O2 Practitioner Certification Certification Portal
OXYGEN LIBRARY
O2 Training vs Therapy PubMed Portal Oxygen Multistep Book Inaccuracy Report
Competitors LiveO2 to EWOT
SUPPORT
970-658-2789 Schedule Appointment Our Team Join a Meeting

Enter Your First Name

Enter your name (3–8 letters) to start the call.

Scientific Overview · Oxygen Physiology · IHHT · Cellular Energy · Research compiled 1950–2024

The Research Basis for Adaptive Oxygen Contrast Training

Abstract

Dr. Manfred von Ardenne’s four-decade research program demonstrated that progressive cardiovascular decline is mediated by a reversible capillary switching mechanism, not irreversible structural damage. This page summarizes the physiological foundation, ten independent peer-reviewed IHHT studies indexed in PubMed, and documented session outcomes supporting intermittent hypoxic-hyperoxic training as a modality for improving cardiovascular function, cellular energy production, and exercise tolerance.

Keywords: IHHT oxygen multistep therapy capillary switching mechanism EPO stimulation mitochondrial oxygen adaptive contrast
IHHT Clinical Trials ↓ References ↓ Schedule a Consultation →
40+Years of Published Research (von Ardenne, 1950s–1997)
10Independent IHHT Studies in PubMed
6+Peer-Reviewed Journals
40+Countries: Clinical & Research Application

The Foundation

The Discovery That Changed Everything

Dr. Manfred von Ardenne identified a “positive feedback loop” embedded in the capillary endothelial cells that line every blood vessel in the body. This loop — which he called a “reversible switching mechanism” — accelerates cardiovascular decline with age as oxygen delivery progressively degrades.

But von Ardenne’s critical finding wasn’t that the loop exists. It was that the mechanism is dynamic and reversible. A specific therapeutic window exists before disease develops where targeted oxygen training can reverse capillary inflammation significantly — restoring delivery pathways that aging and chronic stress had progressively shut down.

His work, published in Oxygen Multistep Therapy and backed by decades of research at the Dresden Research Institute, established the scientific foundation for everything LiveO2 builds. The Adaptive Contrast System is its direct application in a home-use device.

“The endothelial switching mechanism is dynamic in most cases and reversible.” — Dr. Manfred von Ardenne[1]

Selected Publications

  • von Ardenne, M. Oxygen Multistep Therapy: Physiological and Technical Foundations. Georg Thieme Verlag, Stuttgart. 1990. ISBN 0865773777
  • von Ardenne, M., Reitnauer, P.G. Characteristics of cancer cell respiration with reference to oxygen multistep therapy. J Cancer Res Clin Oncol. 1980. PMID: 7430898
  • von Ardenne, M. Permanent multiplication of oxygen transport into tissues by combining O2MT with lowered oxygen binding capacity. Bioelectrochem Bioenerg. 7(4):685–691. 1980.
  • von Ardenne, M. et al. The fate of energy metabolism of the human organism and its modification by multistep oxygen therapy. Z Alternsforsch. 44(1):7–36. 1989. PMID: 2496530
  • Steinhausen, D., Mayer, W.K., von Ardenne, M. Multi-step cancer therapy: clinical results. Strahlenther Onkol. 170(6):322–34. 1994. PMID: 8023241
Dr. Manfred von Ardenne, German physicist and oxygen researcher
Dr. Manfred von Ardenne (1907–1997) — German physicist, inventor of ~600 patents, and founder of oxygen multistep therapy. Photo: Bundesarchiv, used under CC-BY-SA 3.0 DE.

The Problem

Your Lungs Are Fine. The Problem Is Delivery.

Most oxygen problems aren’t absorption failures — they’re delivery failures. Damaged tissue causes blood vessel swelling that creates internal bottlenecks, preventing oxygen-rich blood from reaching the exact areas that need repair.

This creates a vicious cycle: damage blocks oxygen, and without oxygen, damage can’t heal. Standard oxygen therapy adds more oxygen to the lungs but doesn’t solve the delivery blockage. Rest doesn’t solve it either — you can’t rest your way out of a vascular bottleneck.

“You are not just giving the body more oxygen. You are reopening the delivery routes that injury closed down.” — Mark Squibb, LiveO2 Founder

1

Tissue Damage

Blood vessel swelling in damaged areas creates an internal bottleneck. Oxygen-rich blood cannot get through.

2

Bottleneck Blocks Flow

Oxygen-rich blood stalls upstream. Damaged tissue continues starving. More cells go anaerobic. The cycle accelerates.

3

Adaptive Contrast Solution

The hypoxic phase triggers emergency vasodilation. At peak blood flow, the switch to concentrated oxygen floods wide-open vessels with oxygen.

The Mechanism

The Switch That Changes Everything

Adaptive Contrast works by alternating between low-oxygen (hypoxic) and high-oxygen (hyperoxic) air during exercise. The hypoxic phase creates oxygen demand — triggering emergency vasodilation and EPO[2] stimulation. At peak blood flow, the switch to concentrated oxygen floods now-open vessels, forcing oxygen through congested tissue. The complete gradient of oxygen demand and supply is experienced in seconds. This is what passive HBOT and standard EWOT cannot replicate.

1

Challenge

Low-oxygen air triggers emergency vasodilation and EPO production. Blood vessels open to maximum diameter.

2

Switch

At peak vasodilation, oxygen concentration flips to maximum. The delivery network is now fully expanded.

3

Flood

Super-saturated oxygen floods wide-open vessels, penetrating deep tissue that couldn’t be reached before.

Standard EWOT

  • Oxygen-only throughout session
  • Heart rate capped at ~140 BPM
  • No EPO stimulation
  • Delivery routes unchanged

Adaptive Contrast

  • Hypoxic + hyperoxic alternation
  • Full heart rate range supported
  • EPO stimulation triggered
  • Delivery routes reopened

The Data

Observed Outcomes: Documented Session Data

The following outcomes were recorded during actual sessions using calibrated measurement instruments. These are case observations, not controlled clinical trials. Individual results vary.

+29%
Brain Energy Production
Measured via Artinis deep tissue oxygen sensor on prefrontal cortex during a single Adaptive Contrast session. 27% peak spike recorded during protocol.
View Source →
+63%
Composite Memory Score
58-year-old, 41 years post-concussion, single BrainO2 session. Neurological scores confirmed significant recovery across all tested categories.
View Source →
13–29%
Cognitive Improvement
Improvements across 8 neurological categories (CNSVS testing) after just 2 days of training. Measured in a structured concussion experiment.
View Source →
2
Sessions — Parkinson’s Motor Function Improved
Finger tap, balance, and heel-toe testing showed unexpected neurological improvements after two 15-minute sessions. Documented with motion analysis tools.
View Source →
3 Wks
ALS Improvements Lasted
Gait, speech, and breathing improvements documented after two sessions at a conference. Effects persisted for three weeks after the sessions ended.
View Source →

Independent Research

Peer-Reviewed Clinical Evidence for IHHT

LiveO2’s Adaptive Contrast System applies the same physiological principle as Intermittent Hypoxic-Hyperoxic Training (IHHT) — the alternation between low-oxygen and high-oxygen states under exercise load. The following peer-reviewed studies from independent institutions document IHHT outcomes across diverse clinical populations. Studies are indexed in PubMed unless otherwise noted. LiveO2 did not fund or conduct any of the studies listed.

J Cachexia Sarcopenia Muscle 2024 PMID: 39559920
Doehner et al.
IHHT during rehabilitation improved walking distance 2.8-fold and stair climbing power 3.7-fold in long COVID patients versus controls.
Population: Long COVID rehabilitation patients
Alzheimers Dement (N Y) 2017 PMID: 29067323
Bayer et al.
IHHT combined with multimodal training enhanced cognitive function by 16.7% and exercise capacity by 24.1% in geriatric patients.
Population: Geriatric patients with cognitive decline
Biomedicines 2022 PMID: 35327372
Bestavashvili et al.
IHHT significantly decreased systolic and diastolic blood pressure and improved arterial stiffness parameters in metabolic syndrome patients.
Population: Metabolic syndrome patients
Open Heart 2018 PMID: 30487981
Tuter et al.
IHHT preconditioning reduced troponin I levels 24 hours post-coronary artery bypass surgery, indicating reduced myocardial injury compared to controls.
Population: Coronary artery bypass surgery patients
Front Cardiovasc Med 2021 PMID: 34513946
Bestavashvili et al.
IHHT improved lipid profiles and reduced systemic inflammation markers in patients with metabolic syndrome after a structured training protocol.
Population: Metabolic syndrome patients
Front Physiol 2022 PMID: 36388103
Behrendt et al.
IHHT prior to aerobic cycling effectively reduced systolic blood pressure in geriatric patients after six weeks of structured training.
Population: Geriatric patients, 6-week protocol
Clin Cardiol 2017 PMID: 28323322
Glazachev OS, Kopylov PY, Susta D, Dudnik E, et al.
IHHT (10% O₂ / 30% O₂, 3×/week, 3 weeks) improved peak VO₂, reduced systolic blood pressure, lowered LDL-cholesterol, and improved quality of life in CAD patients — with efficacy comparable to an 8-week standard cardiac rehabilitation program.
Population: Coronary artery disease (CAD) patients; n=46, controlled trial
Sports Med Open (Systematic Review) 2022 PMID: 35639211
Behrendt T, Bielitzki R, Behrens M, Herold F, Schega L.
PRISMA-compliant systematic review of 8 chronic IHHE studies found peak VO₂ improvements of 12.6–43.2% in cardiovascular disease populations, reductions in fasting glucose, and evidence of cognitive benefit in elderly patients. Concluded IHH is a “promising non-pharmacological intervention.”
Population: Multiple clinical populations; 8 chronic IHHE studies reviewed
Metabolites (Systematic Review) 2023 PMC: 9961389
Uzun A-B, et al.
PRISMA review of 16 clinical IHHT studies confirmed meaningful improvements across cardiovascular disease, COPD, geriatric, and metabolic syndrome populations. Proposed mechanisms include HIF-1 activation, VEGF upregulation, and improved mitochondrial oxygen utilization. IHHT was well-tolerated in patients up to age 92.
Population: Multiple pathologies; 16 clinical studies reviewed
Front Neurosci 2022 PMID: 35801184
Rybnikova EA, Nalivaeva NN, Zenko MY, Baranova KA.
Review (Pavlov Institute of Physiology, Russian Academy of Sciences) demonstrated that IHT upregulates EPO, promotes neurogenesis and synaptogenesis, improves autonomic nervous system function and arterial stiffness, with high unrealized potential against neurodegeneration and age-related cognitive decline.
Population: Mechanistic review; neurological and cognitive outcomes

These studies were conducted by independent research institutions and are indexed in PubMed. LiveO2 did not fund or conduct these studies. IHHT as studied in these trials uses the same hypoxic-hyperoxic alternation principle as LiveO2’s Adaptive Contrast System.

Mechanism

Chronic Inflammation Is a Plumbing Problem

Vascular cells lining blood vessels depend on dissolved plasma oxygen — not red blood cell oxygen. When plasma oxygen drops below threshold, vascular cells shift to anaerobic metabolism, swell, and create bottlenecks in the capillary network. Downstream tissue starves. More cells go anaerobic. The cycle accelerates.

These “brownout” cells operate in survival mode: accelerated aging, immune invisibility, acid pH shift, chronic fatigue. They don’t respond to rest or supplements because the problem is structural — swollen cells physically block the oxygen supply needed for recovery.

Rest doesn’t fix a plumbing problem. Oxygen delivered under cardiovascular demand — the right kind of oxygen training — does.

“Chronic inflammation isn’t just a buzzword. It’s a plumbing problem — and oxygen is the fix.”

Read: Oxygen Is the Body’s Natural Anti-Inflammatory →

Mechanism

Your Immune System Runs on Oxygen

White blood cells generate energy through aerobic metabolism. At low oxygen levels, immune cells operate at roughly 1/19th their normal power output — fighting like grunts instead of ninjas. Low-power immune responses create chronic inflammation rather than decisive pathogen clearance.

“Brownout zones” — clusters of low-oxygen cells created by vascular bottlenecks — create ideal hiding places for pathogens. The immune system can’t clear what it can’t reach with adequate power. Adaptive Contrast restores immune cell oxygen supply, enabling the full pathogen-clearing response the body was designed to execute.

1/19th Immune cell power capacity at low oxygen levels
100% Immune capacity restored with full oxygenation
Read: Your Immune System Runs on Oxygen →

Clinical Experience

Clinical Practitioner Observations

Dr. Angelique Hart, MD
5 Years Clinical Use · Hundreds of Patients · Albuquerque, NM

“When you improve oxygen delivery first, every other treatment in your protocol works better. It’s the one thing that amplifies everything else.”

✓ Brain Injury Recovery ✓ Chronic Fatigue ✓ Athletic Performance ✓ ~50W Aerobic Output Gain
Read Dr. Hart’s Full Case Review →
Dr. Mike Bauerschmidt, MD
Decade of Clinical Oxygen Therapy Experience

“He bought LiveO2 for himself when mold illness destroyed his memory. After five treatments, his brain clicked back on.”

✓ Mold Illness Recovery ✓ Memory Restoration ✓ Long-Term Clinical Use
Read Dr. Bauerschmidt’s Story →

Comparison

Comparative Analysis: IHHT vs. Hyperbaric Oxygen Therapy

Results

“I see faster and quicker results … and longer-standing results in patients using LiveO2 because they enjoy it, they feel better, and they keep on coming back.” The exercise component creates active cardiovascular demand — driving oxygen through tissue rather than passively pressurizing the lungs.

Cost

Medical hyperbaric chambers cost $40,000–$120,000+ per protocol. LiveO2 is a one-time investment with unlimited home sessions. No per-session fees, no clinic appointments, no scheduling — full control over your protocol.

Residual Effect

“The residual oxygen and therapeutic benefits in your blood can last from weeks up to months … and immunity even longer.” This is backed by a Frontiers in Physiology[3] study on intermittent hypoxic-hyperoxic training showing durable systemic effects well beyond the session itself.

Read the Full HBOT vs. LiveO2 Doctor’s Comparison →

Oxygen Library

Go Deeper

Physiology Oxygen Transport Read Article → Immunity Your Immune System Runs on Oxygen Read Article → Inflammation Oxygen Is the Body’s Natural Anti-Inflammatory Read Article → Brain Research Brain Energy 29% Increase — Measured Read Article → Comparison LiveO2 vs. HBOT — A Doctor’s Comparison Read Article → Education Definitive Guide to EWOT Read Article →

References

  1. von Ardenne, M. Oxygen Multistep Therapy: Physiological and Technical Foundations. Georg Thieme Verlag, Stuttgart, 1990.
  2. von Ardenne, M., Reitnauer, P.G. Characteristics of cancer cell respiration with special reference to oxygen multi-step therapy. J Cancer Res Clin Oncol. 1980.
  3. Bayer, U., et al. Intermittent hypoxic-hyperoxic training on cognitive performance in geriatric patients. Alzheimers Dement (N Y). 2017. PMID: 29067323
  4. Tuter, D.S., et al. Preconditioning with intermittent hypoxia-hyperoxia in coronary artery bypass surgery. Open Heart. 2018. PMID: 30487981
  5. Bestavashvili, A., et al. IHHT effects on lipid profiles and systemic inflammation in metabolic syndrome. Front Cardiovasc Med. 2021. PMID: 34513946
  6. Bestavashvili, A., et al. IHHT effects on blood pressure and arterial stiffness in metabolic syndrome. Biomedicines. 2022. PMID: 35327372
  7. Behrendt, T., et al. IHHT and systolic blood pressure reduction in geriatric patients. Front Physiol. 2022. PMID: 36388103
  8. Doehner, W., et al. IHHT rehabilitation in long COVID: improved walking distance and stair climbing power. J Cachexia Sarcopenia Muscle. 2024. PMID: 39559920
  9. Glazachev, O.S., Kopylov, P.Y., Susta, D., Dudnik, E., et al. Adaptations following an intermittent hypoxia-hyperoxia training in coronary artery disease patients: a controlled study. Clin Cardiol. 2017; 40(6):370–376. PMID: 28323322
  10. Behrendt, T., Bielitzki, R., Behrens, M., Herold, F., Schega, L. Effects of intermittent hypoxia-hyperoxia on performance- and health-related outcomes in humans: a systematic review. Sports Med Open. 2022; 8(1):70. PMID: 35639211
  11. Uzun, A-B., et al. Effectiveness of intermittent hypoxia-hyperoxia therapy in different pathologies with possible metabolic implications. Metabolites. 2023; 13(2):181. PMC: 9961389
  12. Rybnikova, E.A., Nalivaeva, N.N., Zenko, M.Y., Baranova, K.A. Intermittent hypoxic training as an effective tool for increasing the adaptive potential, endurance and working capacity of the brain. Front Neurosci. 2022; 16:941740. PMID: 35801184
  13. von Ardenne, M., Reitnauer, P.G. Characteristics of cancer cell respiration with special reference to oxygen multistep therapy. J Cancer Res Clin Oncol. 1980. PMID: 7430898
  14. Steinhausen, D., Mayer, W.K., von Ardenne, M. Multi-step cancer therapy: clinical results. Strahlenther Onkol. 1994. PMID: 8023241
LiveO2 Expert
Team Available Now

If You’ve Read This Far, You’re Ready for the Conversation

Talk to a real LiveO2 expert — no bots, no scripts. Ask every science question you have.

LiveO2 team available now · Demo slots open this week

Common Questions

Frequently Asked Questions

Standard EWOT delivers high-concentration oxygen throughout an exercise session. Adaptive Contrast adds a second mode — low oxygen (hypoxic) — and alternates between the two in real time. The contrast between hypoxic and hyperoxic phases triggers emergency vasodilation, EPO production, and a cardiovascular response that oxygen-only training cannot produce. The result is up to 600% greater therapeutic effectiveness per session.
Dr. von Ardenne identified a positive feedback loop in capillary endothelial cells — the cells lining your blood vessels. As oxygen delivery degrades, these cells swell and restrict blood flow further, accelerating cardiovascular decline. His critical insight was that this “switching mechanism” is dynamic and reversible in most people before disease has fully set in. Targeted oxygen training can reverse the cascade and restore delivery pathways. This was published in his landmark work, Oxygen Multistep Therapy.
Chronic inflammation is largely a vascular delivery problem. When plasma oxygen drops, the vascular cells lining blood vessels go anaerobic, swell, and create bottlenecks. Downstream tissue starves, more cells go anaerobic, and the cycle accelerates. Oxygen delivered under cardiovascular demand — the way Adaptive Contrast delivers it — reopens the constricted pathways, restoring normal aerobic metabolism. When cells return to aerobic function, the inflammatory signals they were generating stop.
Yes — and this has been measured directly. Using an Artinis deep tissue oxygen sensor placed on the prefrontal cortex, LiveO2 recorded a 29% average increase in brain energy production during a single Adaptive Contrast session, with a 27% peak spike during the protocol itself. This is not a subjective report — it’s a measurement from a calibrated scientific instrument on the brain during the session.
HBOT delivers oxygen under pressure while you rest passively. LiveO2 delivers oxygen during active exercise — and alternates between hypoxic and hyperoxic phases. The exercise creates real cardiovascular demand, driving oxygen into tissue through the circulatory system rather than through pressure alone. Clinicians who have used both report faster results with LiveO2. Cost is also dramatically different: HBOT protocols run $40,000–$120,000+, while LiveO2 is a one-time purchase with unlimited home sessions.
Yes. The foundational science comes from Dr. Manfred von Ardenne’s work, which ran for over 40 years and resulted in peer-reviewed publications on oxygen multistep therapy and the capillary switching mechanism. Beyond von Ardenne’s work, six independent clinical trials published in indexed journals (including Frontiers in Physiology, Open Heart, Alzheimer’s & Dementia, and Biomedicines) document measurable outcomes from Intermittent Hypoxic-Hyperoxic Training — the same physiological principle LiveO2’s Adaptive Contrast System applies. These studies were conducted by independent institutions and are indexed in PubMed. See the References section below for full citations.
LiveO2’s documented experiment library includes cases involving concussion recovery, traumatic brain injury, Parkinson’s motor function, ALS symptom improvement, mold illness, chronic fatigue, athletic performance, and brain energy production. These are documented outcomes from real sessions — not clinical trials or medical claims. LiveO2 is a wellness training device, and results vary. Speaking with a LiveO2 expert directly is the best way to understand what the protocol has shown for conditions similar to yours.
The residual oxygen and circulatory benefits from a session can last from days to weeks — and immune system improvements may last even longer. A 2017 Frontiers in Physiology study on intermittent hypoxic-hyperoxic training found durable systemic effects well beyond the training period itself. With a consistent protocol (typically 3–4 sessions per week), the cumulative effects build over time — improving baseline cardiovascular function, not just producing session-by-session spikes.